India To Produce 850 Million Doses Of Sputnik V Covid-19 Vaccine Annually: RDIF
The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India.
RDIF has agreements with India's Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, and Virchow Biotech for production.
India has become the 60th country to approve Sputnik V, said RDIF CEO, Kirill Dmitriev.
Did you Know
The Russian vaccine has an efficacy of 91.6 percent.